Aisling Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
|
|||||
|
2025
Q1 | $12.6M | Hold |
|
|||||
|
2024
Q4 | $13.6M | Hold |
|
|||||
|
2024
Q3 | $19.7M | Hold |
|
|||||
|
2024
Q2 | $21M | Hold |
|
|||||
|
2024
Q1 | $24.4M | Hold |
|
|||||
|
2023
Q4 | $22.2M | Hold |
|
|||||
|
2023
Q3 | $14.9M | Hold |
|
|||||
|
2023
Q2 | $21.5M | Hold |
|
|||||
|
2023
Q1 | $21.6M | Hold |
|
|||||
|
2022
Q4 | $26.1M | Hold |
|
|||||
|
2022
Q3 | $24.6M | Hold |
|
|||||
|
2022
Q2 | $19.7M | Hold |
|
|||||
|
2022
Q1 | $17.8M | Hold |
|
|||||
|
2021
Q4 | $22.4M | Hold |
|
|||||
|
2021
Q3 | $19.6M | Hold |
|
|||||
|
2021
Q2 | $17.6M | Hold |
|
|||||
|
2021
Q1 | $22.9M | Hold |
|
|||||
|
2020
Q4 | $22.8M | Hold |
|
|||||
|
2020
Q3 | $15.1M | Hold |
|
|||||
|
2020
Q2 | $15.2M | Buy |
|
|||||
|
2020
Q1 | $9.6M | Buy |
|